Biotech Acquisition Co

Biotech Acquisition Co, trading under the ticker BIOT, is a blank-check company formed to pursue a merger or acquisition target in the biotechnology and life sciences sector. The SPAC filed an 8-K with the SEC on January 29, 2021, with accession number 0001213900-21-005456, reflecting activity consistent with its early operational phase following its IPO. Focused on the healthcare and biotech space, BIOT represents the sustained investor appetite for life sciences SPACs that characterized the 2020-2021 SPAC market cycle. Sponsor details remain on file with the Commission. For comprehensive filings, deal timelines, sponsor profiles, and real-time status updates on BIOT and hundreds of other SPACs, sign up for full data access at SpacDesk.